JESSIE RICHEME: Open Payments
NPI 1881222065 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 45 payments from 15 companies in 2025. Trend: 2023 $24 · 2024 $130 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $185 |
| Novo Nordisk Inc | 10 | $184 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $113 |
| Zimmer Biomet Holdings, Inc. | 1 | $113 |
| Sumitomo Pharma America, Inc. | 5 | $107 |
| INTUITIVE SURGICAL, INC. | 1 | $85 |
| Amgen Inc. | 4 | $69 |
| Lilly USA, LLC | 3 | $63 |
| Esperion Therapeutics, Inc. | 3 | $52 |
| Corcept Therapeutics | 2 | $37 |
Products named: VRAYLAR, CAPLYTA, ROSA, GEMTESA, Da Vinci Surgical System, Ozempic, Rybelsus, NEXLETOL.
Industry payments across FL — which companies pay providers there.
